心肌酶谱和肌钙蛋白联合检测对急性心肌梗死的临床意义
摘要
关键词
全文:
PDF参考
[1]Pollard T J The acute myocardial infarction[J]. Prim Care,2000,273:631-649;vi.
[2]Lu L, Liu M, Sun R, et al. Myocardial Infarction: Symptoms and Treatments[J]. Cell Biochem Biophys,2015, 723:865-867.
[3]Frampton J, Ortengren A R and Zeitler E P Arrhythmias After Acute Myocardial Infarction[J]. Yale J Biol Med,2023, 961:83-94.
[4]Salari N, Morddarvanjoghi F, Abdolmaleki A, et al. The global prevalence of myocardial infarction: a systematic review and meta-analysis[J]. BMC Cardiovasc Disord,2023,231:206.
[5]Ponikowski P, Voors A A, Anker S D, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC[J]. Eur Heart J,2016,3727:2129-2200.
[6]Sheifer S E, Manolio T A and Gersh B J Unrecognized myocardial infarction[J]. Ann Intern Med,2001,1359:801- 811.
[7]Fan J, Ma J, Xia N, et al. Clinical Value of Combined Detection of CK-MB,MYO,cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction[J].Clin Lab,2017, 633:427-433.
[8]Timmis A, Vardas P, Townsend N, et al. European Society of Cardiology: cardiovascular disease statistics 2021[J]. Eur Heart J,2022,438:716-799.
[9]Alpert J S, Thygesen K, Antman E, et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J]. J Am Coll Cardiol,2000,363:959-969.
[10]Bajaj A, Sethi A, Rathor P, et al. Acute Complications of Myocardial Infarction in the Current Era: Diagnosis and Management[J]. J Investig Med,2015,637:844-855.
[11]张利红,李亚莉,吴九.阳心肌梗死患者心肌损伤标志物变化及与预后的关系分析[J].医药论坛杂志.2024,4516:1686-1691.
[12]Engel G and Rockson S G Feasibility and Reliability of Rapid Diagnosis of Myocardial Infarction[J]. Am J Med Sci,2020,3592:73-78.
[13]Mathew T P, Menown I B and Adgey A A Optimizing classification of acute myocardial infarction: from diagnosis to prognosis[J]. Eur Heart J,1999,2020:1446-1448.
[14]卢华.血清心肌酶谱、肌钙蛋白Ⅰ与脑钠肽的联合检测诊断急性心肌梗死的临床价值[J].中西医结合心血管病电子杂志,2023,1132:92-94+61.
[15]Espinosa A S, Hussain S, Al-Awar A, et al. Differences between cardiac troponin I vs. T according to the duration of myocardial ischaemia[J]. Eur Heart J Acute Cardiovasc Care,2023,126:355-363.
[16]Shen T, Yang X and Zhang Z Positive Relationship of RDW with NT-proBNP and cTnI in Acute Myocardial Infarction Patients[J]. Clin Lab,2022,686
[17]Li L, Shu X, Zhang L, et al. Evaluation of the analytical and clinical performance of a new high-sensitivity cardiac troponin I assay: hs-cTnI (CLIA) assay[J]. Clin Chem Lab Med,2024,622:353-360.
[18]付春生,张浩,周姝,等.SYNTAX积分联合血清NT-proBNP、CK-MB、cTnⅠ水平对急性心肌梗死患者PCI术预后的评估价值[J].西部医学,2024,3611:1643-1647.
[19]Anastasilakis A D, Koulaxis D, Kefala N, et al. Circulating irisin levels are lower in patients with either stable coronary artery disease (CAD) or myocardial infarction (MI) versus healthy controls, whereas follistatin and activin A levels are higher and can discriminate MI from CAD with similar to CK-MB accuracy[J]. Metabolism,2017,73:1-8.
[20]常琳,张茜,涂胜急性心肌梗死患者心肌损伤标志物水平与心电图分级的关系及其联合早期预测价值[J].中国老年学杂志,2023,4318:4357-4359.
[21]Oxley D K LDH isoenzymes and acute MI[J]. Circulation,1978,585:960.
[22]Zhu T, Han Q, Zhang X, et al. Effects of Xinnaoning combined with trimetazidine on the levels of CK and its isoenzymes, AST, ALT and LDH in patients with myocardial ischemia[J]. Am J Transl Res,2021,134:2875-2882.
[23]Zhang Z,Zhao X,Gao M, et al.Dioscin alleviates myocardial infarction injury via regulating BMP4/NOX1- mediated oxidative stress and inflammation[J]. Phytomedicine, 2022,103:154222.
[24]刘雪平,邓懋清,王文天,等.血清AST、pro-BNP对急性心肌梗死患者的预后预测价值[J].心血管病防治知识,2024,1413:44-47.
(0 摘要 Views, 0 PDF Downloads)
Refbacks
- 当前没有refback。